Introduction
Ischemia-reperfusion (I/R) injury is a clinically relevant phenomenon that is understudied yet has a significant impact on vascularized composite allotransplantation (VCA) outcomes (1, 2) . In solid organ transplantation, I/R injury increases with cold ischemia time and contributes to graft vasculopathy (3) (4) (5) . Furthermore, I/R injury may cause increased cell membrane permeability and cell death, resulting in rhabdomyolysis and organ failure (6) (7) (8) . Unlike solid organs, vascularized composite allografts are comprised of different tissue types and have a significant skeletal muscle component.
Vasculopathy in solid organ transplantation contributes to poor clinical outcomes (4, 9, 10) . While most studies have investigated this phenomenon in the context of inadequate immunosuppression, previous investigations suggest cold ischemia may be an important contributor (11) . Evidence of arterial vasculopathy was discovered in a subset of hand transplant recipients with longer procurement times (12) . In a rat model of hindlimb transplantation, evidence of composite tissue vasculopathy and degeneration (CTVD) was uncovered (13) . Understanding the drivers of this process can illuminate potential preventative and therapeutic strategies for improving patient outcomes.
As there is no specific treatment for I/R injury, preventative strategies aimed at minimizing ischemia time are essential. However, despite obvious clinical significance, very few studies have directly studied the impact of cold ischemia time on VCA and recipient outcomes. Hautz et al found that severe graft tissue inflammation resulted from longer cold ischemia times in a syngeneic rat hindlimb transplantation model (14) . To the best of our knowledge, this study is the first to evaluate mechanisms that initiate innate immune activation in I/Rstressed VCA and delineate the impact of I/R injury for recipient outcomes. First, we developed a clinically relevant model of I/R injury in a syngeneic orthotopic hindlimb transplantation (OHTx) model in mice. Then, we showed how vascular endothelial integrity, regulated by PECAM-1 (CD31), is disrupted by prolonged (6 h or longer) cold ischemia, leading to a crescendo inflammatory response, rhabdomyolysis, remote end-organ damage, and ultimate recipient death.
Materials and Methods

Experimental design
Eight-week-old C57BL/6 male mice (The Jackson Laboratory, Bar Harbor, ME) were housed under standard 12-h light/dark cycle conditions and provided standard food and water ad libitum. Approval was obtained to develop a mouse model of I/R in VCA (OHTx) by the University of California, Los Angeles Institutional Animal and Use Committee, in compliance with the National Institutes of Health "Guide for the Care and Use of Laboratory Animals." Forty-six mice were divided into four experimental groups (n ≥ 5 each). Eight mice were divided into two negative control groups (n = 4 each). The contralateral hindlimbs of recipient mice served as controls. Serum and tissue samples were collected at postoperative days 1 (POD 1) and 3 (POD 3).
Surgical approach
The donor and recipient operations were modified from a model originally described by Sucher et al (15) . Briefly, for the donor operation, an inguinal incision was made, and the femoral artery and vein were isolated and transected just distal to the inguinal ligament. Branches <0.05 mm were ligated with electrocautery to create a 1-cm pedicle, while preserving the epigastric takeoff. Nerves and muscles were transected with a combination of sharp dissection and electrocautery. The femur osteotomy was performed with scissors, and a 21-gauge intramedullary rod was placed. The graft artery was carefully cannulated and flushed with 4°C heparinized University of Wisconsin (UW) solution (50 units in 1 mL over 1 min) until venous return was clear. Customized polyimide cuffs were mounted over each vessel using a 10-0 or 11-0 nylon suture while the graft was placed on a platform chilled to 4°C. The graft was wrapped in UW-soaked gauze and maintained at 4°C for 1 or 6 h.
For the recipient operation, hindlimb amputation was performed after isolation and transection of the femoral vessels just proximal to the epigastric takeoff. The donor graft was taken from cold storage and flushed with 1 mL of lactated Ringer solution and mounted on the recipient femur by using the intramedullary rod. Vessel anastomosis was performed by using the cuff technique, and the muscle and skin were reapproximated with the use of 6-0 Vicryl and 7-0 Prolene, respectively. At the postoperative endpoints, retro-orbital blood collection was performed with the animals under isoflurane anesthesia, and both the transplanted and contralateral hindlimbs were removed for immediate tissue processing. The mice were killed, and the kidneys were collected for paraffin embedding.
Clinical evaluation
Recipients were monitored for survival, general appearance, total body weight, and gross appearance of the transplanted hindlimb. Recipients that appeared markedly ill, as assessed by reduced activity, poor feeding, or other indicators outlined in our institutional IUCAC guidelines, underwent retro-orbital blood collection, euthanasia, and necropsy. Survival curves were generated according to the Kaplan-Meier method, and statistical analyses were performed using the Mantel-Cox log-rank test (p < 0.05).
Histology and immunohistochemistry
Tissues were fixed in 10% phosphate-buffered formalin for 12 h. Paraffin blocks were sectioned into 4-lm-thick slides for hematoxylin-eosin or immunohistochemical staining (PECAM, F4/80, Ly66) and whole-slide digital image capture (Zeiss AxioPhot light microscope; Carl Zeiss Microscopy, Jena, Germany). PECAM density was measured, as described earlier (16) . All slides were divided into three sections and captured at 910 (200 lm) (AxioPhot Aperio Imagescope v12.2.2.5015).
High-throughput multiplex cytokine analysis
OHTx muscle tissue was collected immediately after euthanasia, snapfrozen in liquid nitrogen, and stored at À80°C until further processing. Samples were thawed at 4°C and homogenized over ice in 1.6 mL of ice-cold lysis buffer (20 mmol/L HEPES [pH 7.9], 25% glycerol, 400 mmol/L NaCl, 1 mmol/L EDTA, 1 mmol/L EGTA, protease inhibitor, and phosphatase inhibitor). Homogenates were incubated for 20 min at 4°C under continuous rotation then centrifuged for 30 min at 14 000 9 g at 4°C. The supernatant was collected and a bicinchoninic acid assay was performed to determine total protein concentration. Aliquots of 2 lg/lL (for a total protein concentration of 50 lg/25-lL reaction) were stored at À80°C for future immunoassay profiling (Luminex xMAP; EMD Millipore, Billerica, MA). Samples were compared with lyophilized quality control by using standard curves generated for each analyte (five-parameter, R 2 ≥ 0.997).
Results
Development of a murine model of I/R injury in VCA
We established a new and clinically relevant murine model of OHTx (C57/BL6?C57/BL6) with ex vivo cold storage (4°C in UW solution for 1 or 6 h). This allowed us to focus on I/R-mediated VCA damage itself, without the confounding effects of host allorejection response. A total of 46 OHTx recipients surviving until the predetermined endpoints of POD 1 or 3 were included in experimental analyses. Necropsies performed on animals that died or were killed (excluded from analyses) confirmed the absence of technical error or surgical complications, such as arterial or venous graft thrombosis, hemorrhage, and gross evidence of distal embolus or thrombosis in remote organs. There was no difference in warm ischemia times, mean donor hindlimb weights, or ratios of donor hindlimb weight to recipient bodyweight (p > 0.05 by t-tests, Table 1 ).
Long-term survival was significantly lower for 6 h of cold storage compared with 1-h recipients (p < 0.0005 by Kaplan-Meier log-rank test, Figure 1 ). All recipients maintaining OHTx stored for 1 h at 4°C survived in the long term (>25 days; n = 5). In contrast, eight of nine mice receiving grafts stored for 6 h died between PODs 2 and 3 (n = 9), and no recipient survived by day 25 posttransplantation. Mice in the latter group demonstrated poor feeding, reduced activity, and weakness as evaluated by a veterinarian. Recipients of 1-h cold-stored grafts resumed normal activity patterns by POD 1. In all cases, the hindlimb surgical site remained intact without evidence of arterial or venous occlusion.
Neutrophil infiltration in OHTx peaks by day 3 in the extended cold ischemia group Initial neutrophil and macrophage infiltration was comparable at POD 1 between the two groups, although both demonstrated an increase in staining compared with matched contralateral controls (all data analyzed by multiple-comparison two-way analysis of variance [ANOVA], Figure 2 ). By POD 3, both 1-h and 6-h OHTx recipients demonstrated significantly increased macrophage infiltration compared with contralateral controls (p < 0.05). In contrast, neutrophil infiltration was significantly and selectively elevated by POD 3 in the 6-h group (p < 0.05) compared with the 1-h group and matched contralateral controls. Negative controls exposed to 1 or 6 h of cold storage alone did not show a significantly different cellular infiltration profile over contralateral controls.
Vascular endothelial integrity in OHTx is preserved in short, but not long, cold ischemia times PECAM-1 expression was elevated in the 1-h storage group compared with contralateral controls at POD 1 (p < 0.01, multiple-comparison two-way ANOVA, Figure 3 ). This effect was preserved in this group at POD 3 (p < 0.05). In contrast, there was only a slight rise in PECAM expression between the contralateral leg and 6-h OHTx groups on POD 1. This effect was lost on POD 3, and there was no elevation in PECAM expression in the 6-h cold storage group. Similarly, a slight increase in PECAM-1 expression in matched contralateral controls was not statistically significant.
Renal damage ensues after prolonged cold storage in OHTx recipients Kidneys harvested from 6-h OHTx recipients demonstrated tubular vacuolization and casts, consistent with rhabdomyolysis-induced renal injury (Figure 4 ). Hematoxylin-eosin findings were consistent with acute tubular necrosis associated with myoglobin cast nephropathy, including tubular epithelial vacuolization and luminal translucent eosinophilic casts. These were accompanied by markedly elevated levels of creatinine, creatine kinase, and blood urea nitrogen for the 6-h versus 1-h cold storage group (p = 0.02, p = 0.01, and p = 0.003, respectively, via unpaired t-tests). In contrast, kidneys from 1-h stored OHTx recipients demonstrated no evidence of parenchymal damage or impaired function.
Proinflammatory cytokine profile of I/R-stressed OHTx tissues A heatmap was generated for serum and muscle Luminex analysis ( Figure 5) . Serum values showed greater expression of several proinflammatory cytokines, includinggranulocyte-colony stimulating factor (G-CSF), IL-1a/b, IL-6, IL-10, RANTES, and tumor necrosis factor (TNF)a. The peak cytokine levels were observed at POD 1 in the 6-h OHTx group, with several fold greater expression compared with all other groups. Similar findings were noted from the muscle biopsy specimens with a few notable differences: several cytokines were below the lowest level of detection (interferon [IFN]c, IL-4, IL-12, IL-13, IL-15, and RANTES), and cytokines that were detected were consistent across almost all animals included in the study. The data show a greater variation and range of cytokine levels in the serum compared with muscle biopsy specimens.
In the muscle, G-CSF, granulocyte-macrophage colonystimulating factor (GM-CSF), IL-1a, IL-2, IL-6, IL-9, IL-10, macrophage inflammatory proteins (MIP-1a/b and MIP-2), monocyte chemoattractant protein-1 (MCP-1), and TNFa were all fivefold to 10-fold greater in the 6-h group at POD 1 compared with all other groups and demonstrated the highest 90th percentile of expression.
Of interest is the finding that IL-1a and IL-2 were elevated to the greatest degree in contralateral control muscle biopsies for both the 1-h and 6-h groups. This rise was attenuated in the 6-h compared with the 1-h OHTx recipients. Both negative control groups (1 h and 6 h of cold storage without reperfusion) showed the lowest levels of expression for all cytokines tested, at or below the 10th percentile of expression. The contralateral control muscle biopsy specimens for both 1-h and 6-h OHTx expressed higher levels of IL-1a, IL-2, IL-10, and MIP-1a, in the 90th percentile. 
Discussion
Vascularized composite allografts are designated as organs under the National Organ Transplantation Act, and more than 21 transplant centers in the United States are certified to perform these novel life-enhancing procedures. With the refinement of surgical techniques and implementation of immunomodulation protocols, the indications for VCA are ever-expanding beyond hands and faces that are composed of relatively little muscle to total arms, legs, and abdominal walls, which have a much larger muscle bulk component. Therefore, in the future, a larger cohort of patients will receive grafts with a significant muscle component. Currently, there is no consensus as to the cut-off threshold for acceptable cold ischemia time in clinical VCA. The general consensus is extrapolated from replantation surgery where cold ischemia times of less than 10-12 h for amputations proximal to the wrist (muscle content) and 24 h for fingers (no muscle content) are deemed acceptable. Clearly, understanding the impact of cold ischemia time on clinical outcomes is critical to guide VCA procurement, allocation practices, and surgical techniques to minimize the risk:
benefit ratio. Prevention of I/R-triggered VCA damage could extend the donor transfer time, allowing development of national HLA-VCA matching program. Such a system would reduce the incidence of acute and chronic rejection and minimize the immunosuppressive load.
In this study, we show that OHTx mouse recipients exposed to I/R injury undergo a cascade of innate immune-mediated multitissue damage with local and systemic effects, observed not only in serum cytokine and chemistry levels but also in contralateral muscle biopsy specimens and remote organs, such as the kidney. We also demonstrate vascular endothelial integrity is disrupted in transplanted muscle, which is recoverable after 1 h, but not 6 h, of cold storage. Hence, these findings in a murine model suggest that prolonged I/R stress in VCA (unlike solid organ grafts) can trigger uncorrectable systemic effects, leading even to recipient death. In the clinical setting, it is not uncommon for hand or face transplant procedures to involve cold ischemia times of greater than 6 h, particularly when transport time is factored in. While the mouse model may be particularly sensitive due to the relatively large muscle burden, the overall message we propose is that I/R injury can cause systemic effects in VCA due to the muscular component and must be taken into consideration.
Creatinine, creatine kinase, and blood urea nitrogen were significantly increased in the 6-h cold-storage OHTx recipients. Animals in this group often did not survive beyond POD 2, suggesting they were unable to recover from progressive reperfusion injury. While the 1-h OHTx recipients demonstrated elevated serum chemistries compared with baseline controls, their levels decreased by POD 3. The end-organ damage seen on histology of kidney samples is in a pattern consistent with rhabdomyolysis (17) . Despite identical surgical approaches aside from cold ischemia time, the 6-h OHTx recipients were unable to recover from the local tissue damage. When skeletal muscle undergoes ischemia, cellular function dearrangement results, including lactic acid accumulation, decreased intracellular pH, and ATP depletion (6) . Muscle cells become primed for reperfusion injury, which triggers a distinct cascade of further intracellular changes that contribute to ultimate cell death. With the resulting myonecrosis, large chains of myoglobin are released into the extracellular and interstitial fluids, causing acute kidney injury (18) . This explains the progressive decline of the 6-h OHTx recipients and increased mortality.
We suspect that with longer ischemia times, a progressive inflammatory response with myonecrosis develops, which is irrecoverable beyond 6 h of storage. This observation is supported by the derangements in PECAM-1 expression in muscle biopsy specimens. The signaling receptor in vascular endothelium plays an important role in influencing vascular integrity, angiogenesis, transendothelial leukocyte migration (19) , and cytokine production (20) . Indeed, PECAM-1-deficient mice exposed to endothelial injury have prolonged bleeding times (21), increased permeability, and fatal drops in blood pressure (22, 23) . In this mouse VCA model, the hindlimb is approximately 8-10% of bodyweight. By comparison, the human arm is approximately 2-3% of bodyweight (24) . This murine model likely has a higher graft-to-bodyweight ratio than most current VCA transplanted in humans; however, the pathophysiology might be similar. The long-term impact of I/R-induced VCA rhabdomyolysis has not been investigated in the clinical setting, and our experimental data suggest it should be an important consideration.
Injury to the vascular endothelium results in extrusion of cytokine-rich plasma and recruitment of inflammatory cells. Mechanistic studies by Privatsky et al and others have shown that vascular integrity is a critical regulatory component of the activation, maintenance, and resolution of the inflammatory response (20) . This process is an integral part of the injury response; however, overexuberant cytokine production can promote irrecoverable tissue destruction, with local and systemic effects (25) . I/R injury is well known to contribute to this effect, with the length of ischemia time directly correlated to the severity of tissue damage (26) . Blockade of PECAM-1 has been shown to protect against I/R injury in rat muscle flaps (11) and improve capillary blood flow.
Interestingly, PECAM-1 exerts both proinflammatory and anti-inflammatory effects; while it promotes transendothelial leukocyte migration and activation, it concurrently attenuates cellular activation and cytokine release and restores disrupted vascular integrity (20, 22) . It is likely that the initial response to injury triggers a complex signaling cascade that also promotes resolution of the injury response (27) . Our data show PECAM-1 expression declined from POD 1 to POD 3 in muscle biopsy specimens from both 1-h and 6-h cold ischemia OHTx recipients; this effect is more pronounced in the 6-h cold storage group (p = 0.01). This finding is consistent with previous studies showing upregulation of PECAM-1 expression with damaging stimuli and shows that a longer cold ischemia time impairs PECAM-1 expression in muscle capillaries. As PECAM-1 attenuates local and systemic proinflammatory cytokine levels in mice (20, 22, 23, 28) , we postulate that with impaired expression of PECAM-1 in I/R-damaged VCA, this attenuation response is blunted.
Luminex analysis confers a considerable advantage for detecting and quantifying cytokines over conventional techniques such as enzyme-linked immunosorbent assay due to the ability measure several related cytokines simultaneously (29, 30) . The multiplex panel used in this study offers novel insight into the cytokines that play a major role in the response to I/R injury in VCA that have not previously been assessed in the literature, such as the MIP chemokine family. Known interactions between cytokines and their relative expression can suggest the important pathways that trigger IRI in VCA. The reproducibility, reliability, and validity of Luminex technology has been previously established in serum/cell suspensions (30, 31) . The current analysis represents the first assessment of muscle biopsy specimens in VCAs.
Neutrophil recruitment is an essential mediator of I/R injury (5, 8) , and MIP-1 and keratinocyte-derived chemokine fractions are highest in the 6-h POD 1 group. RANTES and MCP-1 also recruit and activate monocytes and macrophages and have been implicated in allograft vasculopathy. Longer cold ischemia times correlate with graded induction of transcription factors such as nuclear factor-jB, correlating with increasing expression of inflammatory cytokines such as IL-1b, IL-6, IFNc, and TNFa. In animal models, IFNc is necessary and sufficient to induce vasculopathy, while TNFa modulates this response. Gene expression of TNFa, MIP-2, and IL-6 is nuclear factor-jB dependent (3, 4) ; our Luminex multiplex data ares consistent with the expected elevated levels in serum and muscle for the prolonged cold ischemia group at POD 1. It is likely this effect diminishes by POD 3, as the critical period for macrophage and neutrophil recruitment has ended. This may also explain the increased mortality in the 6-h cold-stored OHTx recipient group, which did not survive the cytokine storm by POD 2.
In conclusion, this study in a mouse model of OHTx is the first to document that prolonged cold ischemia time in VCA triggers not only progressive local I/R injury but also remote tissue dysfunction in transplant recipients.
Minimizing cold ischemia time to 1 h limited inflammatory cell infiltration, cytokine release, and endothelial dysfunction, resulting in improved survival. These experimental findings suggest that VCA procurement policies and surgical techniques in clinical settings should be structured to maximally limit cold ischemia time. As a real-life example with our clinical VCA program, we have limited our donor catchment area to minimize travel time and modified the actual transplant procedure so that revascularization is performed before the repair of other structures such as tendons and nerves all in an effort to minimize cold ischemia time and I/R-associated potential rhabdomyolysis.
